-
Apple's $17B Smartwatch Business At Risk, Cutting-Edge AI Tech 'HUGS' And More: This Week In Appleverse
Sunday, December 24, 2023 - 8:43am | 816Read More...As the week comes to a close, we take a look back at the major developments that have shaped the business landscape. This week was particularly eventful for tech giant Apple Inc. (NASDAQ:AAPL), with a string of stories making headlines across the globe. From threats to its smartwatch operations to...
-
'They Haven't Called:' Masimo CEO Awaits Apple's Move In Watch Patent Infringement Dispute
Wednesday, December 20, 2023 - 2:33am | 667Read More...Masimo Corp. (NASDAQ:MASI) CEO Joe Kiani has expressed his willingness to settle the ongoing rift with Apple Inc. (NASDAQ:AAPL) over patent infringements related to the Apple Watch Ultra 2 and Apple Watch Series 9. What Happened: In an ...
-
Apple's Timepiece Trouble: Patent Dispute Puts Apple Watch Imports In Jeopardy
Friday, October 27, 2023 - 6:29am | 731Read More...In the latest update on the patent dispute between Apple Inc. (NASDAQ:AAPL) and medical technology firm Masimo (NASDAQ:MASI), the U.S. International Trade Commission or ITC has issued a potential ban on Cupertino from importing its Apple Watch. What Happened:...
-
Masimo, Medical Device Maker Drops On Q2 Guidance, Opportunity?
Wednesday, July 26, 2023 - 11:53am | 693Read More...Shares of health monitoring technology maker Masimo Corporation (NASDAQ: MASI) dropped 24% to $114.30 last week due to a second-quarter performance warning. They are at their lowest level since January 2019 — but according to Wall Street, could have healthy gains ahead. The Irvine,...
-
Piper Jaffray Comments On Masimo 1Q11 Results
Wednesday, May 4, 2011 - 7:31am | 112Read More...According to Piper Jaffray, Masimo (NASDAQ: MASI) reported 1Q11 revenue above its and Street consensus expectations, with in-line EPS. Piper Jaffray said that rainbow was below estimate due to the timing of last year's large military order, but much stronger than expected SET revenue drove 1Q11...
-
Piper Jaffray Reiterates Overweight on Masimo Corporation (MASI)
Friday, March 11, 2011 - 8:54am | 146Read More...Piper Jaffray is out with its report today on Masimo Corporation (NASDAQ: MASI), reiterating Overweight. In a note to clients, Piper Jaffray writes, "A little noticed provision within the Covidien (Nellcor)/Masimo agreement suggests that if Nellcor introduces any additional parameters, the new...
-
Masimo To Negotiate Lower Royalties From COV Post 1Q11, Bets Citigroup
Tuesday, January 11, 2011 - 9:56am | 160Read More...Citigroup has published a research report on Masimo Corporation (NASDAQ: MASI) after the company encouraged the Street to remove COV's royalty stream post 1Q11, and Citi believes a lower royalty rate will most likely be negotiated. In the report, Citigroup writes "The covenant requires COV to pay...
